Sun Yat-sen University: all 1,680 studies

Page 6 of 17. Open to participants first (609), then studies with results posted, then the rest; newest registration first within each.

• Assessment of Early-detection Based on Liquid Biopsy in Lymphoid MalignanciesRecruitingNCT05275036
• PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal CancerRecruitingNCT05236972Phase 3
• A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric CancerRecruitingNCT05235906Phase 2
• Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon CancersRecruitingNCT05194878Phase 3
• Ovarian Function of Nasopharyngeal Carcinoma Women SurvivorsNot yet recruitingNCT05183724
• JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal CarcinomaRecruitingNCT05173246Phase 2
• Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast CancerNot yet recruitingNCT05172518Phase 3
• Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction AdenocarcinomaRecruitingNCT05170503Phase 2
• Comparison of Posterior Continuous Curvilinear Capsulorhexis With or Without Anterior VitrectomyRecruitingNCT05136209Not applicable
• Corticosteroid Combining Noncorticosteroid Systemic Immunomodulatory Therapy in VKHRecruitingNCT05120687
• Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi)RecruitingNCT05116579
• Multi-model Image of Doxycycline in TAORecruitingNCT05112211Not applicable
• Multi-model Image of Immunosuppressive Agents in TAORecruitingNCT05110040Not applicable
• Prospective Cohort Study on Prognosis of Patients With Hepatitis B/CNot yet recruitingNCT05102838
• Adjuvant Chemotherapy for High-risk Postenucleation RetinoblastomaRecruitingNCT05080010Phase 3
• Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors.RecruitingNCT05072327Not applicable
• Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)RecruitingNCT05044117Phase 3
• Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLCRecruitingNCT05011487Phase 2
• Observational Study of Factors Predicting Therapeutic Effects and Clinical Prognosis After HAIC for Locally Advanced HCCRecruitingNCT05002452
• Sintilimab in Combination With Chidamide in Newly Diagnosed ENKTCLRecruitingNCT04994210Phase 2
• Orelabrutinib Plus Rituximab Followed by Maintenance With Orelabrutinib for Relapsed and Refractory Follicular Lymphoma(RR FL)RecruitingNCT04989621Phase 2
• Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer PatientsRecruitingNCT04980716Phase 3
• Monitoring Minimal Residual Disease（MRD）in Pediatric B-acute Lymphoblastic LeukemiaRecruitingNCT04977895
• The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical StudyRecruitingNCT04957901
• Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal CarcinomaRecruitingNCT04944914Phase 3
• Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast CancerRecruitingNCT04941885Phase 2
• Fulvestrant Plus Anlotinib in HR(+)/HER2(-) Metastatic Breast Cancer With FGFR MutationRecruitingNCT04936295Phase 2
• Long-term Prognosis of Patients With Sepsis After ImmunotherapyNot yet recruitingNCT04901104
• An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPCNot yet recruitingNCT04890522Phase 2/3
• Albumin-bound Paclitaxel Combined With Liposomal Doxorubicin in the Treatment of Advanced or Unresectable AngiosarcomaRecruitingNCT04859465Phase 2
• the SDMEAI Study: a Multi-center Epidemiological StudyNot yet recruitingNCT04849819
• A Multi-center, Non-randomized, Open-label Phase II Clinical Study on the Treatment of Newly Diagnosed Advanced Hodgkin's Lymphoma With PD-1 Antibody (Tislelizumab) Combined With AVD Regimen (Doxorubicin, Vindesine, Dacarbazine) Under the Guidance of PET/CTRecruitingNCT04843267Phase 2
• Neurocognition in NSCLC Patients Treated With Osimertinib or Osimertinib + WBIRecruitingNCT04829019Phase 2
• Neoadjuvant Camrelizumab in Combination With Cisplatin and Nab-paclitaxel in Resectable HNSCCRecruitingNCT04826679Phase 2
• Topotecan and Melphalan for RetinoblastomaRecruitingNCT04799002Phase 3
• Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal CarcinomaRecruitingNCT04778956Phase 3
• Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)RecruitingNCT04777942Not applicable
• Zanubrutinib-based Induction and Maintenance Therapy in Young and Fit Patients With Untreated Mantle Cell LymphomaRecruitingNCT04736914Phase 2
• PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome PatientsRecruitingNCT04711434Phase 3
• Lymphadenectomy in Early Ovarian CancerRecruitingNCT04710797Not applicable
• Comparison of HBV Reactivation Between Patients With High HBV-DNA and Low HBV-DNA Loads Undergoing ICI and Concurrent Antiviral Prophylaxis: a Prospective Observational StudyRecruitingNCT04680598
• PD-1 Inhibitor or PD-1 Inhibitor Plus GVD for Relapsed/Refractory CHLRecruitingNCT04624984Phase 2
• Tislelizumab or Tislelizumab Combined With Lenvatinib Neo-adjuvant Treatment for Resectable RHCCRecruitingNCT04615143Phase 2
• Umbrella Biomarker-Guided Therapy in NPCNot yet recruitingNCT04605562Phase 2
• Adriamycin and Ifosfamide Combined With SintilimabRecruitingNCT04589754Phase 2
• Toripalimab Combined With CAV/IE RegimenRecruitingNCT04589741Phase 2
• Prognostic Nomogram of Extranodal NK/T-cell LymphomaRecruitingNCT04554511
• Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPCRecruitingNCT04544969
• A Phase II Clinical Study of Treprilimab in the Treatment of Recurrent Nasopharyngeal Carcinoma After Re-irradiationNot yet recruitingNCT04534855Phase 2
• Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 TrialRecruitingNCT04502641Phase 3
• Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II StudyRecruitingNCT04454905Phase 2
• Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal CarcinomaRecruitingNCT04453826Phase 3
• Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal CarcinomaRecruitingNCT04453813Phase 3
• Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal CarcinomaRecruitingNCT04448522Phase 3
• Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With MalnutritionRecruitingNCT04436965Phase 3
• SBRT Versus Ablation for Perivascular Hepatocellular CarcinomaRecruitingNCT04434989Not applicable
• Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized Recurrent Nasopharyngeal CarcinomaRecruitingNCT04425265Not applicable
• Neo-TACE-HAIC for BCLC B Stage HCCRecruitingNCT04424043Not applicable
• A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)RecruitingNCT04365036Phase 3
• mFOLFOXIRI Versus mFOLFOX6 as Adjuvant Chemotherapy for Locally Advanced Colorectal CancerRecruitingNCT04338191Phase 3
• Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell LymphomaRecruitingNCT04329130Phase 2
• Effectiveness of Using Interactive Consulting System to Enhance Informed ChoiceRecruitingNCT04246346Not applicable
• A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC ClassificationRecruitingNCT04191889Phase 2
• Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal CarcinomaRecruitingNCT04136886Phase 3
• HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized TrialRecruitingNCT04135690Phase 2
• mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer PatientsRecruitingNCT04084496Phase 2
• A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With LBLRecruitingNCT03971318
• A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With Systemic ALK(+) ALCLRecruitingNCT03971305
• Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With BL/DLBCLRecruitingNCT03958916
• Neoadjuvant Toripalimab With or Without Celecoxib in dMMR/MSI-H Colorectal CancerRecruitingNCT03926338Phase 2
• PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma PatientsRecruitingNCT03907826Phase 3
• Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLCRecruitingNCT03872661Phase 2
• Shenzhen Birth Cohort StudyRecruitingNCT03830879
• Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And NeckRecruitingNCT03830385Phase 2
• Toripalimab（JS001） as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid TumorsRecruitingNCT03810339Phase 2
• To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr /ISGs.RecruitingNCT03771677Not applicable
• Randomized Study of Adjuvant Radiotherapy After Curative Resection of HCC With Narrow Margin (RAISE)RecruitingNCT03732105Not applicable
• Matching Glaucoma With Impaired CognitionRecruitingNCT03695224
• Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term RadiationRecruitingNCT03671252Phase 3
• VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple MyelomaRecruitingNCT03641456Phase 2
• PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal CancerRecruitingNCT03638297Phase 2
• Nanshan Elderly Cohort StudyRecruitingNCT03569735
• A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTientsRecruitingNCT03561740Phase 3
• CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and RadiotherapyNot yet recruitingNCT03529279Phase 3
• Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPCNot yet recruitingNCT03503136Phase 3
• A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer (With Pelvic or Para-aortic Node Involvement)RecruitingNCT03468010Phase 3
• Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable FactorRecruitingNCT03399253Phase 2/3
• The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.RecruitingNCT03368651Phase 3
• Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma PatientsRecruitingNCT03353467Not applicable
• A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRCRecruitingNCT03303495Phase 3
• Clinical Trial of Neoadjuvant Targeted Treatment to NSCLC PatientsNot yet recruitingNCT03203590Phase 3
• A Trial Comparing Observation With Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical CancerRecruitingNCT03071289Phase 3
• High Quality Evidence of Chinese Lupus Nephritis (HELP)RecruitingNCT03001973
• IgA Nephropathy Registration Initiative of High Quality (INSIGHT)RecruitingNCT03001947
• Super Chinese Nephrotic Syndrome Registration System (SUCCESS)RecruitingNCT03001934
• Wise Practice of Chinese Hemodialysis (WISHES)RecruitingNCT03001921
• Peritoneal Dialysis Registration System (PERSIST)RecruitingNCT02989298
• IgA Nephropathy Biomarkers Evaluation Study (INTEREST)RecruitingNCT02954419
• Esthetic, Clinical and Radiographic Outcomes of Immediate and Delayed Implant PlacementRecruitingNCT02814149Not applicable
• Laparoscopic Surgery VS RFA for Recurrent HCCNot yet recruitingNCT02785380Phase 4

← Sun Yat-sen University overview and focus areas